These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6688837)

  • 1. [Mechanism of action of penicillamine D in the neonatal period].
    Oroszlán G; Lakatos L; Karmazsin L
    Kinderarztl Prax; 1983 Jul; 51(7):333-7. PubMed ID: 6688837
    [No Abstract]   [Full Text] [Related]  

  • 2. D-penicillamine in the prevention of retrolental fibroplasia.
    Lakatos L; Hatvani I; Oroszlán G; Karmazsin L; Matkovics B
    Acta Paediatr Acad Sci Hung; 1982; 23(3):327-35. PubMed ID: 6897477
    [No Abstract]   [Full Text] [Related]  

  • 3. [D-penicillamine does not affect the liver and kidney function in newborn infants nor the in vitro function of phagocytes].
    Csáthy L; Szabó I; Pataki M; Lakatos L; Maródi L
    Orv Hetil; 1991 Nov; 132(44):2421-3. PubMed ID: 1945383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of retinopathy of premature infants with D-penicillamine].
    Lakatos L; Hatvani I; Oroszlán G; Balla G; Karmazsin L; Olubunmi A; Kincses E; Szabó I; Vekerdy Z
    Orv Hetil; 1985 Jun; 126(23):1391-6. PubMed ID: 3892423
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of D-penicillamine on the albumin-bilirubin complex.
    Péter F; Lakatos L; Kövér B
    Acta Paediatr Acad Sci Hung; 1976; 17(2):103-6. PubMed ID: 1037649
    [No Abstract]   [Full Text] [Related]  

  • 6. D-Penicillamine administration and the incidence of retinopathy of prematurity.
    Christensen RD; Alder SC; Richards SC; Lambert DK; Schmutz N; Wiedmeier SE; Burnett J; Baer VL; Horn JT; Richards M; Barraza J
    J Perinatol; 2007 Feb; 27(2):103-11. PubMed ID: 17262043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-penicillamine and retinopathy of prematurity.
    Lakatos L
    Pediatrics; 1988 Dec; 82(6):951-3. PubMed ID: 3186390
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal oxygen toxicity and its prevention: D-penicillamine offers benefits without harmful side-effects.
    Oroszlán G; Lakatos L; Karmazsin L
    Acta Paediatr Acad Sci Hung; 1982; 23(4):459-71. PubMed ID: 6763447
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental data on the prevention of retrolental fibroplasia by D-penicillamine.
    Karmazsin L; Lakatos L; Balla G; Makay A; Hatvani L
    Acta Paediatr Acad Sci Hung; 1980; 21(2-3):131-8. PubMed ID: 6894055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates.
    Christensen RD; Alder SC; Richards SC; Horn JT; Lambert DK; Baer VL
    J Perinatol; 2006 Feb; 26(2):120-4. PubMed ID: 16407960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Penicillamine D therapy of hyperbilirubinemia in premature infants].
    Korányi G; Kovács J; Vörös I
    Orv Hetil; 1978 Jan; 119(3):149-53. PubMed ID: 622268
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of short time phenobarbital treatment on neonatal jaundice].
    Zwacka G; Frenzel J
    Padiatr Padol; 1971 Mar; 6(1):102-7. PubMed ID: 5155604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of published recommendations for screening studies of retinopathy of prematurity].
    Kellner U; Jandeck C; Helbig H; Versmold H; Bossi E; Körner F; Foerster MH
    Ophthalmologe; 1995 Oct; 92(5):681-4. PubMed ID: 8750996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine and retinopathy of prematurity.
    Hatvani IL; Lakatos L
    Am J Ophthalmol; 1983 May; 95(5):719-20. PubMed ID: 6687784
    [No Abstract]   [Full Text] [Related]  

  • 15. An audit of the 1995 Royal College of Ophthalmologists guidelines for screening for retinopathy of prematurity applied retrospectively in one regional neonatal intensive care unit.
    Fleck BW; Wright E; Dhillon B; Millar GT; Laing IA
    Eye (Lond); 1995; 9 ( Pt 6 Su)():31-5. PubMed ID: 8729016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hyperbilirrubinemia in the newborn].
    Delgado A
    An Esp Pediatr; 1977 Oct; 10(10):731-44. PubMed ID: 564653
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China.
    Chen Y; Li XX; Yin H; Gilbert C; Liang JH; Jiang YR; Zhao MW;
    Br J Ophthalmol; 2008 Mar; 92(3):326-30. PubMed ID: 18303154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression.
    Lakatos L
    Am J Pathol; 1998 May; 152(5):1397-8. PubMed ID: 9588908
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for retinopathy of prematurity--a problem solved?
    Flynn JT; Sola A; Good WV; Phibbs RH
    Pediatrics; 1995 May; 95(5):755-7. PubMed ID: 7724317
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries.
    Jalali S; Matalia J; Hussain A; Anand R
    Am J Ophthalmol; 2006 May; 141(5):966-8. PubMed ID: 16678524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.